Matches in SemOpenAlex for { <https://semopenalex.org/work/W4372270908> ?p ?o ?g. }
- W4372270908 endingPage "880" @default.
- W4372270908 startingPage "874" @default.
- W4372270908 abstract "Abstract Allogeneic hematopoietic cell transplantation is a potentially curative treatment in high-risk acute lymphoblastic leukemia (ALL). Conditioning regimens based on ≥12 Gray total body irradiation (TBI) represent the current standard in patients ≤45 years, whereas elderly patients frequently receive intermediate intensity conditioning (IIC) to reduce toxicity. To evaluate the role of TBI as a backbone of IIC in ALL, a retrospective, registry-based study included patients >45 years transplanted from matched donors in first complete remission, who had received either fludarabine/TBI 8 Gy (FluTBI8, n = 262), or the most popular, irradiation-free alternative fludarabine/busulfan, comprising busulfan 6.4 mg/kg (FluBu6.4, n = 188) or 9.6 mg/kg (FluBu9.6, n = 51). At two years, overall survival (OS) was 68.5%, 57%, and 62.2%, leukemia-free survival (LFS) was 58%, 42.7%, and 45%, relapse incidence (RI) was 27.2%, 40%, and 30.9%, and non-relapse-mortality (NRM) was 23.1%, 20.7%, and 26.8% for patients receiving FluTBI8Gy, FluBu6.4, and FluBu9.6, respectively. In multivariate analysis, the risk of NRM, acute and chronic graft-versus-host disease was not influenced by conditioning. However, RI was higher after FluBu6.4 (hazard ratio [HR] [95% CI]: 1.85 [1.16–2.95]), and LFS was lower after both FluBu6.4 (HR: 1.56 [1.09–2.23]) and FluBu9.6 (HR: 1.63 [1.02–2.58]) as compared to FluTBI8. Although only resulting in a non-significant advantage in OS, this observation indicates a stronger anti-leukemic efficacy of TBI-based intermediate intensity conditioning." @default.
- W4372270908 created "2023-05-07" @default.
- W4372270908 creator A5000598699 @default.
- W4372270908 creator A5006288618 @default.
- W4372270908 creator A5007367389 @default.
- W4372270908 creator A5011372127 @default.
- W4372270908 creator A5012691135 @default.
- W4372270908 creator A5013640134 @default.
- W4372270908 creator A5018033667 @default.
- W4372270908 creator A5020996390 @default.
- W4372270908 creator A5022161221 @default.
- W4372270908 creator A5023183268 @default.
- W4372270908 creator A5026667594 @default.
- W4372270908 creator A5036207495 @default.
- W4372270908 creator A5040417184 @default.
- W4372270908 creator A5042552205 @default.
- W4372270908 creator A5047411729 @default.
- W4372270908 creator A5058925624 @default.
- W4372270908 creator A5059990245 @default.
- W4372270908 creator A5081937285 @default.
- W4372270908 creator A5086317399 @default.
- W4372270908 creator A5088266782 @default.
- W4372270908 creator A5088962035 @default.
- W4372270908 creator A5089360800 @default.
- W4372270908 date "2023-05-05" @default.
- W4372270908 modified "2023-10-18" @default.
- W4372270908 title "Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT" @default.
- W4372270908 cites W1506738181 @default.
- W4372270908 cites W1838408716 @default.
- W4372270908 cites W1975323495 @default.
- W4372270908 cites W1989658067 @default.
- W4372270908 cites W1999402052 @default.
- W4372270908 cites W2015184525 @default.
- W4372270908 cites W2069377065 @default.
- W4372270908 cites W2086891287 @default.
- W4372270908 cites W2139098185 @default.
- W4372270908 cites W2202787089 @default.
- W4372270908 cites W2379365975 @default.
- W4372270908 cites W2424740985 @default.
- W4372270908 cites W2509076190 @default.
- W4372270908 cites W2529791032 @default.
- W4372270908 cites W2566332174 @default.
- W4372270908 cites W2618073389 @default.
- W4372270908 cites W2773570824 @default.
- W4372270908 cites W2789806594 @default.
- W4372270908 cites W2883172656 @default.
- W4372270908 cites W2890866210 @default.
- W4372270908 cites W2944618076 @default.
- W4372270908 cites W2965729011 @default.
- W4372270908 cites W2981828827 @default.
- W4372270908 cites W3022929575 @default.
- W4372270908 cites W3026313166 @default.
- W4372270908 cites W3031569017 @default.
- W4372270908 cites W3034343309 @default.
- W4372270908 cites W3083549720 @default.
- W4372270908 cites W3111565569 @default.
- W4372270908 cites W3112175219 @default.
- W4372270908 cites W3127374472 @default.
- W4372270908 cites W3132424591 @default.
- W4372270908 cites W3142115670 @default.
- W4372270908 cites W3146530070 @default.
- W4372270908 cites W3195823962 @default.
- W4372270908 cites W3198812267 @default.
- W4372270908 cites W3214674851 @default.
- W4372270908 cites W3215424713 @default.
- W4372270908 cites W4206037399 @default.
- W4372270908 cites W4210565782 @default.
- W4372270908 cites W4295028880 @default.
- W4372270908 cites W4318168202 @default.
- W4372270908 doi "https://doi.org/10.1038/s41409-023-01966-w" @default.
- W4372270908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37147469" @default.
- W4372270908 hasPublicationYear "2023" @default.
- W4372270908 type Work @default.
- W4372270908 citedByCount "1" @default.
- W4372270908 countsByYear W43722709082023 @default.
- W4372270908 crossrefType "journal-article" @default.
- W4372270908 hasAuthorship W4372270908A5000598699 @default.
- W4372270908 hasAuthorship W4372270908A5006288618 @default.
- W4372270908 hasAuthorship W4372270908A5007367389 @default.
- W4372270908 hasAuthorship W4372270908A5011372127 @default.
- W4372270908 hasAuthorship W4372270908A5012691135 @default.
- W4372270908 hasAuthorship W4372270908A5013640134 @default.
- W4372270908 hasAuthorship W4372270908A5018033667 @default.
- W4372270908 hasAuthorship W4372270908A5020996390 @default.
- W4372270908 hasAuthorship W4372270908A5022161221 @default.
- W4372270908 hasAuthorship W4372270908A5023183268 @default.
- W4372270908 hasAuthorship W4372270908A5026667594 @default.
- W4372270908 hasAuthorship W4372270908A5036207495 @default.
- W4372270908 hasAuthorship W4372270908A5040417184 @default.
- W4372270908 hasAuthorship W4372270908A5042552205 @default.
- W4372270908 hasAuthorship W4372270908A5047411729 @default.
- W4372270908 hasAuthorship W4372270908A5058925624 @default.
- W4372270908 hasAuthorship W4372270908A5059990245 @default.
- W4372270908 hasAuthorship W4372270908A5081937285 @default.
- W4372270908 hasAuthorship W4372270908A5086317399 @default.
- W4372270908 hasAuthorship W4372270908A5088266782 @default.
- W4372270908 hasAuthorship W4372270908A5088962035 @default.
- W4372270908 hasAuthorship W4372270908A5089360800 @default.